Key result
Automated light transmission aggregometry on the Sysmex CS-2500 showed significant correlation with traditional manual LTA for maximal aggregation response across multiple agonists (p<0.001).
Why the study?
Does automated platelet aggregometry on the Sysmex CS-2500 correlate with traditional manual LTA in patients with suspected platelet disorders or on antiplatelet therapy?
Observational (n=49)
No
Does automated platelet aggregometry on the Sysmex CS-2500 correlate with traditional manual LTA in patients with suspected platelet disorders or on antiplatelet therapy?
p-value: p=< .001
Automated platelet aggregometry on the Sysmex CS-2500 correlates significantly with manual LTA, offering a less labor-intensive alternative for platelet function assessment.
May support automated LTA in clinical labs; leaves open prospective validation before routine use.
Light transmission aggregometry (LTA) is still considered as the "gold standard" for platelet function assessment but, as acompletely manual technology, it is labour intensive. This challenge can be overcome by performing platelet aggregometry in anautomated method on a routine coagulation analyzer. We aimed to compare and correlate results obtained from a traditional manual LTA solution realized in our Reference Center with an optimized automated system using CE-marked agonist reagents. Platelet rich plasma from patients with suspected platelet disorders, von Willebrand disease or antiplatelet therapy have been assessed using a wide range of agonist concentrations. Results were expressed as Maximal Platelet Aggregation and correlation was analyzed using the Passing and Bablok regression test. Platelet aggregometry studies were performed in 49 samples. Maximal aggregation response with ADP (0.5-10 μM), collagen (2 mg/μL), ristocetin (1.2 mg/mL) and arachidonic acid (1 mM) agonists showed significant correlation between the two aggregometers (p< .001). We observed a more variable response using lowconcentrations of ADP (≤5 μM). Moreover, we also noted discrepancies with the low dose of ristocetin, showing excessive paradoxical agglutination with the CS-2500, suggesting that a lower ristocetin dose should be used with this system. These data show that CS-2500 has the advantages of a walk-away technology and the use of CE-marked reagents also permit the possibility of an easier certification.
No takes yet. Share an insight, caveat, or question.
Bret et al. (2018) conducted an observational in Suspected platelet disorders, von Willebrand disease, or antiplatelet therapy (n=49). Automated light transmission aggregometry on Sysmex CS-2500 vs. Traditional manual light transmission aggregometry was evaluated on Maximal Platelet Aggregation correlation (p=< .001). Automated light transmission aggregometry on the Sysmex CS-2500 showed significant correlation with traditional manual LTA for maximal aggregation response across multiple agonists (p<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: